Intervention 216 children were allocated to early (defined as "as soon as possible") insertion of tympanostomy tubes, and 213 were allocated to late (defined as up to 9 mo later if effusion persisted) insertion of tympanostomy tubes (66 of the 196 children tested [34%] received tubes by 3 y of age).
Main outcome measures
Developmental outcomes, including speech, language, cognition, and psychosocial development (parenting stress and child behaviour) at 3 years of age.
Main results
At 3 years of age, no statistically significant differences existed between the treatment groups for any of the outcomes (table) .
Conclusion
In young children with persistent otitis media with effusion within the durations studied, prompt insertion of tympanostomy tubes did not improve developmental outcomes at 3 years of age. 
COMMENTARY
This trial by Paradise et al is methodologically sound by prevailing standards. Its presentation uses the standard deviation, which is a generally understandable metric of magnitude. Among other virtues, this approach helps to clarify that the treatment effects on the particular sample are truly null.
Under caveats, the authors acknowledge that more positive results, both on developmental sequelae of OME and on remediation by ventilation tube treatment, could have occurred with older or with more stringently defined patients. In the delayed treatment control group, 117 children (64%) had effusion for more than half the time. Let us take this proportion as typical for all the entrants. Such a subgroup of children might show benefit in a future trial. The inclusion criteria also led to most children having only unilateral effusion. In many countries, such children would not be considered for treatment. The surveillance and intervention implied by the entry criterion are comparable to those in a trial by Rovers et al.
1 Together, these 2 null trials indicate that treating near-normal patients for a mild non-progressive condition is usually neither wise nor cost effective. Despite the expectations of some US clinicians, null results were likely because of the very high spontaneous remission rate at this age for fluid in the ears and the dilution of treatment effects according to how developmentally "downstream" the measures considered are (eg, language development).
In conclusion, some children with OME may benefit from tube insertion. Unfortunately, the data reported from this trial do not allow us to delimit which ones. Nevertheless, the high intervention rates in some countries are challenged, and more secure evidence of severity, persistence, and impact of disease, beyond its mere presence, should inform the decision to place tubes. Clinical policies in those countries will probably become more conservative.
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